F Schmalzl
Overview
Explore the profile of F Schmalzl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zwierzina H, Schollenberger S, Herold M, Schmalzl F, Besemer J
Leuk Res
. 1992 Dec;
16(12):1181-6.
PMID: 1465026
The majority of patients suffering from myelodysplastic syndromes (MDS) die of complications due to cytopenia. Clinical trials have demonstrated that in an essential number of MDS patients cytopenia can be...
2.
Herold M, Schmalzl F, Zwierzina H
Leuk Res
. 1992 Jun;
16(6-7):585-8.
PMID: 1635376
Serum concentration of interleukin 6 (IL-6) was measured in 45 patients with myelodysplastic syndromes (MDS). A commercially available enzyme-linked immunosorbent assay (ELISA) with a sensitivity of 3 pg/ml was used....
3.
Zwierzina H, Herold M, Schollenberger S, Geissler D, Schmalzl F
Br J Haematol
. 1991 Nov;
79(3):438-43.
PMID: 1751371
Sera of 15 healthy controls and 33 patients suffering from myelodysplastic syndromes (MDS) were investigated for soluble interleukin-2 receptor (sIL-2R) expression with a cell-free enzyme-linked immunosorbent assay (ELISA) system (T-Cell...
4.
Zwierzina H, Herold M, Geissler D, Schollenberger S, Schmalzl F
Blood
. 1991 Jun;
77(12):2795-6.
PMID: 2043776
No abstract available.
5.
Sepp N, Zwierzina H, Smolle J, Schmalzl F, Fritsch P, Schuler G
J Invest Dermatol
. 1991 Jun;
96(6):932-6.
PMID: 2045682
The myelodysplastic syndromes (MDS) represent clonal disorders of the hematopoietic stem cell that are associated with quantitative and qualitative disturbances of the peripheral blood cells and a high risk for...
6.
Zwierzina H, Mufti G, Schmalzl F
Leukemia
. 1991 Feb;
5(2):166-85.
PMID: 1708435
No abstract available.
7.
Zwierzina H, Hoffmann S, Schmalzl F, BRAUNSTEINER H
Wien Med Wochenschr
. 1991 Jan;
141(14):311-20.
PMID: 1949830
Hematopoietic growth factors represent a subgroup of the cytokines and are also called colony-stimulating factors (CSFs) because of their effects in bone marrow culture. These glycoproteins are produced by a...
8.
Zwierzina H, Schmalzl F, BRAUNSTEINER H
Acta Med Austriaca
. 1991 Jan;
18(1):24-7.
PMID: 1862698
Cytokines are mainly produced by monocytes and lymphocytes and influence a broad spectrum of physiological processes within the hematopoietic and the immune system. Clinical trials have mainly been initiated with...
9.
Nachbaur D, Denz H, Zwierzina H, Schmalzl F, HUBER H
Cancer Lett
. 1990 Apr;
50(3):197-201.
PMID: 2157547
We studied the effects human recombinant granulocyte-macrophage colony-stimulating factor and human recombinant interleukin-3 on the colony formation of three human solid tumor cell lines. Using a modified double-layer soft agar...
10.
Geissler D, Zwierzina H, Pechlaner C, Gaggl S, Schmalzl F, Konwalinka G, et al.
Br J Haematol
. 1989 Sep;
73(1):29-35.
PMID: 2679861
In 13 patients with myelodysplastic syndrome (MDS) mature and immature erythropoietic (CFU-E, BFU-E), granulopoietic (CFU-GM) and megakaryopoietic (CFU-Meg) colony formation from human bone marrow mononuclear cells was evaluated in a...